Cargando…

High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses

High content image-based screening was developed as an approach to test a protease inhibitor small molecule library for antiviral activity against Rift Valley fever virus (RVFV) and to determine their mechanism of action. RVFV is the causative agent of severe disease of humans and animals throughout...

Descripción completa

Detalles Bibliográficos
Autores principales: Mudhasani, Rajini, Kota, Krishna P., Retterer, Cary, Tran, Julie P., Whitehouse, Chris A., Bavari, Sina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140764/
https://www.ncbi.nlm.nih.gov/pubmed/25144302
http://dx.doi.org/10.1371/journal.pntd.0003095
_version_ 1782331559162937344
author Mudhasani, Rajini
Kota, Krishna P.
Retterer, Cary
Tran, Julie P.
Whitehouse, Chris A.
Bavari, Sina
author_facet Mudhasani, Rajini
Kota, Krishna P.
Retterer, Cary
Tran, Julie P.
Whitehouse, Chris A.
Bavari, Sina
author_sort Mudhasani, Rajini
collection PubMed
description High content image-based screening was developed as an approach to test a protease inhibitor small molecule library for antiviral activity against Rift Valley fever virus (RVFV) and to determine their mechanism of action. RVFV is the causative agent of severe disease of humans and animals throughout Africa and the Arabian Peninsula. Of the 849 compounds screened, 34 compounds exhibited ≥50% inhibition against RVFV. All of the hit compounds could be classified into 4 distinct groups based on their unique chemical backbone. Some of the compounds also showed broad antiviral activity against several highly pathogenic RNA viruses including Ebola, Marburg, Venezuela equine encephalitis, and Lassa viruses. Four hit compounds (C795-0925, D011-2120, F694-1532 and G202-0362), which were most active against RVFV and showed broad-spectrum antiviral activity, were selected for further evaluation for their cytotoxicity, dose response profile, and mode of action using classical virological methods and high-content imaging analysis. Time-of-addition assays in RVFV infections suggested that D011-2120 and G202-0362 targeted virus egress, while C795-0925 and F694-1532 inhibited virus replication. We showed that D011-2120 exhibited its antiviral effects by blocking microtubule polymerization, thereby disrupting the Golgi complex and inhibiting viral trafficking to the plasma membrane during virus egress. While G202-0362 also affected virus egress, it appears to do so by a different mechanism, namely by blocking virus budding from the trans Golgi. F694-1532 inhibited viral replication, but also appeared to inhibit overall cellular gene expression. However, G202-0362 and C795-0925 did not alter any of the morphological features that we examined and thus may prove to be good candidates for antiviral drug development. Overall this work demonstrates that high-content image analysis can be used to screen chemical libraries for new antivirals and to determine their mechanism of action and any possible deleterious effects on host cellular biology.
format Online
Article
Text
id pubmed-4140764
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41407642014-08-25 High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses Mudhasani, Rajini Kota, Krishna P. Retterer, Cary Tran, Julie P. Whitehouse, Chris A. Bavari, Sina PLoS Negl Trop Dis Research Article High content image-based screening was developed as an approach to test a protease inhibitor small molecule library for antiviral activity against Rift Valley fever virus (RVFV) and to determine their mechanism of action. RVFV is the causative agent of severe disease of humans and animals throughout Africa and the Arabian Peninsula. Of the 849 compounds screened, 34 compounds exhibited ≥50% inhibition against RVFV. All of the hit compounds could be classified into 4 distinct groups based on their unique chemical backbone. Some of the compounds also showed broad antiviral activity against several highly pathogenic RNA viruses including Ebola, Marburg, Venezuela equine encephalitis, and Lassa viruses. Four hit compounds (C795-0925, D011-2120, F694-1532 and G202-0362), which were most active against RVFV and showed broad-spectrum antiviral activity, were selected for further evaluation for their cytotoxicity, dose response profile, and mode of action using classical virological methods and high-content imaging analysis. Time-of-addition assays in RVFV infections suggested that D011-2120 and G202-0362 targeted virus egress, while C795-0925 and F694-1532 inhibited virus replication. We showed that D011-2120 exhibited its antiviral effects by blocking microtubule polymerization, thereby disrupting the Golgi complex and inhibiting viral trafficking to the plasma membrane during virus egress. While G202-0362 also affected virus egress, it appears to do so by a different mechanism, namely by blocking virus budding from the trans Golgi. F694-1532 inhibited viral replication, but also appeared to inhibit overall cellular gene expression. However, G202-0362 and C795-0925 did not alter any of the morphological features that we examined and thus may prove to be good candidates for antiviral drug development. Overall this work demonstrates that high-content image analysis can be used to screen chemical libraries for new antivirals and to determine their mechanism of action and any possible deleterious effects on host cellular biology. Public Library of Science 2014-08-21 /pmc/articles/PMC4140764/ /pubmed/25144302 http://dx.doi.org/10.1371/journal.pntd.0003095 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Mudhasani, Rajini
Kota, Krishna P.
Retterer, Cary
Tran, Julie P.
Whitehouse, Chris A.
Bavari, Sina
High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses
title High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses
title_full High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses
title_fullStr High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses
title_full_unstemmed High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses
title_short High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses
title_sort high content image-based screening of a protease inhibitor library reveals compounds broadly active against rift valley fever virus and other highly pathogenic rna viruses
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140764/
https://www.ncbi.nlm.nih.gov/pubmed/25144302
http://dx.doi.org/10.1371/journal.pntd.0003095
work_keys_str_mv AT mudhasanirajini highcontentimagebasedscreeningofaproteaseinhibitorlibraryrevealscompoundsbroadlyactiveagainstriftvalleyfevervirusandotherhighlypathogenicrnaviruses
AT kotakrishnap highcontentimagebasedscreeningofaproteaseinhibitorlibraryrevealscompoundsbroadlyactiveagainstriftvalleyfevervirusandotherhighlypathogenicrnaviruses
AT retterercary highcontentimagebasedscreeningofaproteaseinhibitorlibraryrevealscompoundsbroadlyactiveagainstriftvalleyfevervirusandotherhighlypathogenicrnaviruses
AT tranjuliep highcontentimagebasedscreeningofaproteaseinhibitorlibraryrevealscompoundsbroadlyactiveagainstriftvalleyfevervirusandotherhighlypathogenicrnaviruses
AT whitehousechrisa highcontentimagebasedscreeningofaproteaseinhibitorlibraryrevealscompoundsbroadlyactiveagainstriftvalleyfevervirusandotherhighlypathogenicrnaviruses
AT bavarisina highcontentimagebasedscreeningofaproteaseinhibitorlibraryrevealscompoundsbroadlyactiveagainstriftvalleyfevervirusandotherhighlypathogenicrnaviruses